Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • Alovudine - HIV Infections
    Clinical Study Number 1211.1
    Study Indication HIV Infections
    Product Alovudine
    Generic Name Alovudine
    Lab Code
    Clinical Phase IIa
    Study Title

    Randomised, Double Blind, Placebo-controlled Dose Ranging Trial to Determine the Antiviral Activity and Safety of Alovudine in Nucleoside-experienced HIV-infected Subjects Experiencing Virologic Failure

    Study Document
    Trial synopsis 1211.1 english